Entwicklung und Validierung des Stapesplasty Outcome Test25 (SPOT-25)

Entwicklung und Validierung des Stapesplasty Outcome Test25 (SPOT-25) net. Diese α-Version wurde Stapesplasty Background. Otosclerosis affects health- Results. The SPOT-25 showed a high internal Outcome Test 47 (SPOT-47; . Tab. 1) related quality of life (HRQOL). Until now, consistency (Cronbach’s α > 0.7), allowed genannt. measurements have only been performed discrimination between otosclerosis patients Die statistische Auswertung erfolgte using audiometric data or non-validated and healthy subjects, and demonstrated quality of life questionnaires. acceptable test–retest reliability (r = 0.85). mit der Statistiksowa ft re JMP 5.1. (SAS Objective. The objective of this study was to After stapes surgery, the HRQOL improved Institute, Cary, NC, USA). develop the first validated disease-specific significantly. The responsiveness was high. Zur Itembewertung und Itemreduk- HRQOL measuring instrument to determine Conclusion. TheSPOT-25 is thefirst validated tion erfolgte eine sequenzielle statisti- HRQOL in otosclerosis. disease-specific instrument for HRQOL sche Analyse. Diese enthielt eine Einzel- Materials and methods. After sequential measurement in otosclerosis patients. It analysis and item reduction of the initial should be used routinely for quality control. itemanalyse,eineBewertungderinternen Stapesplasty Outcome Test 47 (SPOT-47), Konsistenz, der Konstruktvalidität und the SPOT-25 was validated prospectively on Keywords der Divergenzvalidität. Da sich im Sha- 52 otosclerosis patients undergoing stapes Patient-reported Outcomes · Outcome piro-Wilk-Test keine Normalverteilung surgery. In http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png HNO Springer Journals

Entwicklung und Validierung des Stapesplasty Outcome Test25 (SPOT-25)

Loading next page...
 
/lp/springer_journal/entwicklung-und-validierung-des-stapesplasty-outcome-test25-spot-25-eg4jJpizpi
Publisher
Springer Medizin
Copyright
Copyright © 2017 by Springer Medizin Verlag GmbH
Subject
Medicine & Public Health; Otorhinolaryngology; Neurosurgery
ISSN
0017-6192
eISSN
1433-0458
D.O.I.
10.1007/s00106-017-0389-x
Publisher site
See Article on Publisher Site

Abstract

net. Diese α-Version wurde Stapesplasty Background. Otosclerosis affects health- Results. The SPOT-25 showed a high internal Outcome Test 47 (SPOT-47; . Tab. 1) related quality of life (HRQOL). Until now, consistency (Cronbach’s α > 0.7), allowed genannt. measurements have only been performed discrimination between otosclerosis patients Die statistische Auswertung erfolgte using audiometric data or non-validated and healthy subjects, and demonstrated quality of life questionnaires. acceptable test–retest reliability (r = 0.85). mit der Statistiksowa ft re JMP 5.1. (SAS Objective. The objective of this study was to After stapes surgery, the HRQOL improved Institute, Cary, NC, USA). develop the first validated disease-specific significantly. The responsiveness was high. Zur Itembewertung und Itemreduk- HRQOL measuring instrument to determine Conclusion. TheSPOT-25 is thefirst validated tion erfolgte eine sequenzielle statisti- HRQOL in otosclerosis. disease-specific instrument for HRQOL sche Analyse. Diese enthielt eine Einzel- Materials and methods. After sequential measurement in otosclerosis patients. It analysis and item reduction of the initial should be used routinely for quality control. itemanalyse,eineBewertungderinternen Stapesplasty Outcome Test 47 (SPOT-47), Konsistenz, der Konstruktvalidität und the SPOT-25 was validated prospectively on Keywords der Divergenzvalidität. Da sich im Sha- 52 otosclerosis patients undergoing stapes Patient-reported Outcomes · Outcome piro-Wilk-Test keine Normalverteilung surgery. In

Journal

HNOSpringer Journals

Published: Jul 17, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off